Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)

Historic Interest Coverage Ratio for Gyre Therapeutics (GYRE) over the last 10 years, with Q1 2024 value amounting to 25.62.

  • Gyre Therapeutics' Interest Coverage Ratio rose 14722.52% to 25.62 in Q1 2024 from the same period last year, while for Dec 2024 it was 51.31, marking a year-over-year increase of 14907.49%. This contributed to the annual value of 25.92 for FY2023, which is 48694.61% down from last year.
  • According to the latest figures from Q1 2024, Gyre Therapeutics' Interest Coverage Ratio is 25.62, which was up 14722.52% from 10.36 recorded in Q1 2023.
  • Gyre Therapeutics' Interest Coverage Ratio's 5-year high stood at 25.62 during Q1 2024, with a 5-year trough of 2300.0 in Q3 2020.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 183.23 (2020), whereas its average is 660.21.
  • Over the last 5 years, Gyre Therapeutics' Interest Coverage Ratio had its largest YoY gain of 14722.52% in 2024, and its largest YoY loss of 14722.52% in 2024.
  • Gyre Therapeutics' Interest Coverage Ratio (Quarter) stood at 376.82 in 2020, then skyrocketed by 102.75% to 10.36 in 2023, then surged by 147.23% to 25.62 in 2024.
  • Its Interest Coverage Ratio stands at 25.62 for Q1 2024, versus 10.36 for Q1 2023 and 376.82 for Q4 2020.